Serum Levels of IL-1β, IL-6, TGF-β, and MMP-9 in Patients Undergoing Carotid Artery Stenting and Regulation of MMP-9 in a New In Vitro Model of THP-1 Cells Activated by Stenting

Figure 1

Interleukin-1β (IL-1β), interleukin-6 (IL-6), transforming growth factor-β (TGF-β), and matrix metalloproteinase-9 (MMP-9) serum levels at different time intervals. (a) Serum levels of IL-1β, IL-6 and TGF-β before, 24 hours and 3 months after carotid artery stenting (CAS). (b) Serum MMP-9 levels before, 24 hours, 3 months, and 6 months after CAS. compared with before; compared with 24 hours.

(a)

(b)